Saakshi Medtech and Panels AGM votes and auditors
NSE: SAAKSHIElectrical Equipment
Share price at the NSE close on 28 Oct 2026. Previous close ₹365.00.
28 Oct: open ₹362.00, high ₹365.00, low ₹362.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹716 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 58.25
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.23
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 13,200
Saakshi Medtech and Panels board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Saakshi Medtech and Panels AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Saakshi Medtech and Panels share news and announcements
Annual general meeting, 30 Sep 2026
1,301 shareholders on the register on 23 Sep 2026; present: 3 promoters and 17 others; votes counted by CS ADITYA SANDEEP PATIL / ADITYA PATIL & CO..
- To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31 March 2026, together with the Board’s Report, its annexures and Auditors’ Report thereonOrdinary100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 69.74% · promoters 100.00% · other public 7.83%
To appoint Mr. Nandkumar Vasant Dhekne (DIN: 02189370) as a Non-Executive Independent Director for three consecutive years from 30 September 2026 to 29 September 2029, not liable to retire by rotation.MoreLess
OrdinaryPromoters have an interest in it100.00% for0.00% againstAgainst: promoters 0.00% · other public 0.00%
Turnout: all 65.51% · promoters 93.70% · other public 7.83%
To appoint Mr. Nandkumar Vasant Dhekne (DIN: 02189370) as a Non-Executive Independent Director for three consecutive years from 30 September 2026 to 29 September 2029, not liable to retire by rotation.MoreLess
Special100.00% for0.00% againstAgainst: promoters 0.00% · other public 0.00%
Turnout: all 69.74% · promoters 100.00% · other public 7.83%
- To appoint Mr. Ravi Madhav Vartak (DIN: 11898942), Additional Director appointed with effect from 19 August 2026, as a Director liable to retire by rotationOrdinary100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 69.74% · promoters 100.00% · other public 7.83%
To reappoint Mr. Aniket Vijay Latkar (DIN: 03312108) as Chairman and Managing Director for five years from 8 June 2026 to 7 June 2031, with remuneration and other terms set out in the AGM Notice and Explanatory StatementMoreLess
SpecialPromoters have an interest in it100.00% for0.00% againstAgainst: promoters 0.00% · other public 0.00%
Turnout: all 66.29% · promoters 94.87% · other public 7.83%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Extraordinary general meeting, 2 Jun 2026, 2 resolutions
1,562 shareholders on the register on 26 May 2026; present: 3 promoters and 23 others; votes counted by JAY PANDYA / JAY PANDYA & ASSOCIATES.
- To Increase in Authorized Capital of the Company and consequential Alteration in the Capital Clause of Memorandum of Association of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 76.58% · promoters 100.00% · institutions 0.00% · other public 7.10%
- To Approve the issue of Equity Shares of the Company on Preferential Basis for consideration other than cashSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 76.58% · promoters 100.00% · institutions 0.00% · other public 7.10%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
The company's own answers in its filing.
How money raised was used
The company's results filing for the quarter to Mar 2026 says no statement of how money raised was used applies to it.